Toth Financial Advisory’s Amneal Pharmaceuticals AMRX Stock Holding History

Toth Financial Advisory’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.3K	Hold	1,000	–	–	﹤0.01%	517
2026 Q1	$12.4K	Hold	1,000	–	–	﹤0.01%	536
2025 Q4	$12.6K	Hold	1,000	–	–	﹤0.01%	525
2025 Q3	$10K	Hold	1,000	–	–	﹤0.01%	538
2025 Q2	$8.09K	Hold	1,000	–	–	﹤0.01%	511
2025 Q1	$8.38K	Hold	1,000	–	–	﹤0.01%	475
2024 Q4	$7.92K	Hold	1,000	–	–	﹤0.01%	473
2024 Q3	$8.32K	Hold	1,000	–	–	﹤0.01%	468
2024 Q2	$6.35K	Hold	1,000	–	–	﹤0.01%	504
2024 Q1	$6.06K	Hold	1,000	–	–	﹤0.01%	502
2023 Q4	$6.07K	Hold	1,000	–	–	﹤0.01%	508
2023 Q3	$4.22K	Hold	1,000	–	–	﹤0.01%	552
2023 Q2	$3.1K	Hold	1,000	–	–	﹤0.01%	597
2023 Q1	$1.39K	Hold	1,000	–	–	﹤0.01%	719
2022 Q4	$1.99K	Hold	1,000	–	–	﹤0.01%	592
2022 Q3	$2K	Hold	1,000	–	–	﹤0.01%	622
2022 Q2	$3K	Hold	1,000	–	–	﹤0.01%	542
2022 Q1	$4K	Hold	1,000	–	–	﹤0.01%	554
2021 Q4	$5K	Hold	1,000	–	–	﹤0.01%	558
2021 Q3	$5K	Hold	1,000	–	–	﹤0.01%	551
2021 Q2	$5K	Hold	1,000	–	–	﹤0.01%	502
2021 Q1	$7K	Hold	1,000	–	–	﹤0.01%	490
2020 Q4	$5K	Hold	1,000	–	–	﹤0.01%	455
2020 Q3	$4K	Hold	1,000	–	–	﹤0.01%	438
2020 Q2	$5K	Buy	+1,000	New	+$4.12K	﹤0.01%	403

Other funds holding AMRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Toth Financial Advisory's AMRX Position: Q2 2026 in Review

Toth Financial Advisory held its Amneal Pharmaceuticals (AMRX) position steady in Q2 2026 at 1,000 shares worth $17.3K. The position accounts for ﹤0.01% of the portfolio, ranked #517.

Toth Financial Advisory first reported a position in AMRX in Q2 2020 and has held it in 25 quarters since. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

Toth Financial Advisory held 1,000 shares of Amneal Pharmaceuticals worth $17.3K as of Q2 2026.
Toth Financial Advisory left its Amneal Pharmaceuticals share count unchanged in Q2 2026.
Amneal Pharmaceuticals made up ﹤0.01% of Toth Financial Advisory's portfolio in Q2 2026, its #517 holding.
Toth Financial Advisory first reported a position in Amneal Pharmaceuticals in Q2 2020 and has held it in 25 quarters since.
311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Toth Financial Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.